ArticleNature cancer2023
A designer peptide against the EAG2-Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma.
Weifan Dong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it